Cargando…
Ichthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review
Tyrosine kinase inhibitors have revolutionized the chemotherapy arena as targeted therapies for a multitude of malignancies. They are more selective than conventional chemotherapy, and often elicit fewer systemic adverse events, however toxicities still exist. Cutaneous toxicities are common and the...
Autores principales: | Eber, Ariel E., Rosen, Alyx, Oberlin, Kate E., Giubellino, Alessio, Romanelli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686035/ https://www.ncbi.nlm.nih.gov/pubmed/29138996 http://dx.doi.org/10.1007/s40800-017-0055-y |
Ejemplares similares
-
Ponatinib‐induced ichthyosiform eruption
por: Kluger, Nicolas, et al.
Publicado: (2021) -
Erythroderma secondary to pityriasis rubra pilaris
por: Gómez-Moyano, Elisabeth, et al.
Publicado: (2019) -
Photosensitive pityriasis rubra pilaris
por: Męcińska-Jundziłł, Kaja, et al.
Publicado: (2016) -
Juvenile Pityriasis Rubra Pilaris
por: Xie, Yihang, et al.
Publicado: (2023) -
Pityriasis rubra pilaris-like eruption following insulin therapy initiation
por: Badri, Talel, et al.
Publicado: (2016)